142 related articles for article (PubMed ID: 1869943)
1. Etiology of cerebral vasospasm in primates.
Macdonald RL; Weir BK; Runzer TD; Grace MG; Findlay JM; Saito K; Cook DA; Mielke BW; Kanamaru K
J Neurosurg; 1991 Sep; 75(3):415-24. PubMed ID: 1869943
[TBL] [Abstract][Full Text] [Related]
2. Morphometric analysis of monkey cerebral arteries exposed in vivo to whole blood, oxyhemoglobin, methemoglobin, and bilirubin.
Macdonald RL; Weir BK; Grace MG; Martin TP; Doi M; Cook DA
Blood Vessels; 1991; 28(6):498-510. PubMed ID: 1782405
[TBL] [Abstract][Full Text] [Related]
3. Effect of intrathecal superoxide dismutase and catalase on oxyhemoglobin-induced vasospasm in monkeys.
Macdonald RL; Weir BK; Runzer TD; Grace MG; Poznansky MJ
Neurosurgery; 1992 Apr; 30(4):529-39. PubMed ID: 1584351
[TBL] [Abstract][Full Text] [Related]
4. Temporal changes in perivascular concentrations of oxyhemoglobin, deoxyhemoglobin, and methemoglobin after subarachnoid hemorrhage.
Pluta RM; Afshar JK; Boock RJ; Oldfield EH
J Neurosurg; 1998 Mar; 88(3):557-61. PubMed ID: 9488312
[TBL] [Abstract][Full Text] [Related]
5. Prospective, randomized, double-blind trial of BQ-123 and bosentan for prevention of vasospasm following subarachnoid hemorrhage in monkeys.
Hino A; Weir BK; Macdonald RL; Thisted RA; Kim CJ; Johns LM
J Neurosurg; 1995 Sep; 83(3):503-9. PubMed ID: 7666230
[TBL] [Abstract][Full Text] [Related]
6. Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage.
Pluta RM; Oldfield EH; Boock RJ
J Neurosurg; 1997 Nov; 87(5):746-51. PubMed ID: 9347984
[TBL] [Abstract][Full Text] [Related]
7. Cerebral perivascular nerves in subarachnoid hemorrhage. A histochemical and immunohistochemical study.
Hara H; Nosko M; Weir B
J Neurosurg; 1986 Oct; 65(4):531-9. PubMed ID: 3760964
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y in the primate model of subarachnoid hemorrhage.
Pluta RM; Deka-Starosta A; Zauner A; Morgan JK; Muraszko KM; Oldfield EH
J Neurosurg; 1992 Sep; 77(3):417-23. PubMed ID: 1506889
[TBL] [Abstract][Full Text] [Related]
9. Is vasospasm related to proliferative arteriopathy?
Pluta RM; Zauner A; Morgan JK; Muraszko KM; Oldfield EH
J Neurosurg; 1992 Nov; 77(5):740-8. PubMed ID: 1403117
[TBL] [Abstract][Full Text] [Related]
10. Surgical manipulation of primate cerebral arteries in established vasospasm.
Findlay JM; Macdonald RL; Weir BK; Grace MG
J Neurosurg; 1991 Sep; 75(3):425-32. PubMed ID: 1869944
[TBL] [Abstract][Full Text] [Related]
11. The effect of timing of clot removal on chronic vasospasm in a primate model.
Handa Y; Weir BK; Nosko M; Mosewich R; Tsuji T; Grace M
J Neurosurg; 1987 Oct; 67(4):558-64. PubMed ID: 3655894
[TBL] [Abstract][Full Text] [Related]
12. Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH.
Findlay JM; Weir BK; Steinke D; Tanabe T; Gordon P; Grace M
J Neurosurg; 1988 Nov; 69(5):723-35. PubMed ID: 3141595
[TBL] [Abstract][Full Text] [Related]
13. Malondialdehyde, glutathione peroxidase, and superoxide dismutase in cerebrospinal fluid during cerebral vasospasm in monkeys.
Macdonald RL; Weir BK; Runzer TD; Grace MG
Can J Neurol Sci; 1992 Aug; 19(3):326-32. PubMed ID: 1393841
[TBL] [Abstract][Full Text] [Related]
14. Effect of cyclosporine on the development of cerebral vasospasm in a primate model.
Handa Y; Hayashi M; Takeuchi H; Kobayashi H; Kawano H; Kabuto M
Neurosurgery; 1991 Mar; 28(3):380-5; discussion 385-6. PubMed ID: 2011219
[TBL] [Abstract][Full Text] [Related]
15. Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage.
Pluta RM; Dejam A; Grimes G; Gladwin MT; Oldfield EH
JAMA; 2005 Mar; 293(12):1477-84. PubMed ID: 15784871
[TBL] [Abstract][Full Text] [Related]
16. Role of ferrous iron chelator 2,2'-dipyridyl in preventing delayed vasospasm in a primate model of subarachnoid hemorrhage.
Horky LL; Pluta RM; Boock RJ; Oldfield EH
J Neurosurg; 1998 Feb; 88(2):298-303. PubMed ID: 9452239
[TBL] [Abstract][Full Text] [Related]
17. Controlled release of a nitric oxide donor for the prevention of delayed cerebral vasospasm following experimental subarachnoid hemorrhage in nonhuman primates.
Clatterbuck RE; Gailloud P; Tierney T; Clatterbuck VM; Murphy KJ; Tamargo RJ
J Neurosurg; 2005 Oct; 103(4):745-51. PubMed ID: 16266059
[TBL] [Abstract][Full Text] [Related]
18. The effect of timing of intrathecal fibrinolytic therapy on cerebral vasospasm in a primate model of subarachnoid hemorrhage.
Findlay JM; Weir BK; Kanamaru K; Grace M; Baughman R
Neurosurgery; 1990 Feb; 26(2):201-6. PubMed ID: 2106630
[TBL] [Abstract][Full Text] [Related]
19. Effects of nitroglycerin on vasospasm and cyclic nucleotides in a primate model of subarachnoid hemorrhage.
Nakao K; Murata H; Kanamaru K; Waga S
Stroke; 1996 Oct; 27(10):1882-7; discussion 1887-8. PubMed ID: 8841348
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal fibrinolytic therapy after subarachnoid hemorrhage: dosage study in a primate model and review of the literature.
Findlay JM; Weir BK; Kanamaru K; Grace M; Gordon P; Baughman R; Howarth A
Can J Neurol Sci; 1989 Feb; 16(1):28-40. PubMed ID: 2493974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
